Global 3D Bioprinted Human Tissue Market Anticipated to Expand Rapidly From 2025 to 2029
Use Code ONLINE20 to Save 20% On Global Market Reports — Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
What Is the Current Size and Annual Growth Rate of the 3D Bioprinted Human Tissue Market?
The 3D bioprinted human tissue market size has grown rapidly in recent years. It will grow from $1.70 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing demand for organ transplantation, rising incidence of chronic diseases, growing investment in regenerative medicine, expansion of stem cell research, and increasing use of personalized medicine.
The 3D bioprinted human tissue market size is expected to see rapid growth in the next few years. It will grow to $3.18 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing demand for organ transplantation, rising incidence of chronic diseases, growing investment in regenerative medicine, expansion of stem cell research, and increasing use of personalized medicine. Major trends in the forecast period include advancements in bio-ink technologies, innovations in tissue engineering, rapid developments in stem cell bioprinting, research and development activities, and the emergence of multi-material and multi-cell printing systems.
Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27196&type=smp
What Are the Primary Factors Driving the 3D Bioprinted Human Tissue Market?
The increasing demand for organ transplants is expected to propel the growth of the 3D bioprinted human tissue market going forward. Organ transplantation refers to the medical procedure of transferring organs from a donor to a recipient to replace damaged or failing organs. The growing demand for organ transplants is due to patients seeking life-saving procedures that reduce waiting times, improve survival rates, and offer hope through accessible and reliable transplant solutions. 3D bioprinted human tissue offers a transformative solution for organ transplants by enabling the creation of patient-specific, functional tissues that reduce rejection risk and lessen dependence on donor organs. For instance, in January 2024, according to the Organ Procurement and Transplantation Network, a US-based department of health and human services, organ transplants from living and deceased donors totaled 46,632 in 2023, an increase of 8.7% over 2022 and 12.7% over 2021, the first year that more than 40,000 organ transplants were performed. Therefore, the increasing demand for organ transplants is driving the growth of the 3D bioprinted human tissue market.
How Is the 3D Bioprinted Human Tissue Market Categorized Based on Key Segments?
The 3D bioprinted human tissue market covered in this report is segmented
1) By Tissue Type: Skin, Cartilage, Liver, Bone, Heart, Other Tissue Types
2) By Technology: Extrusion-Based, Inkjet Bioprinting, Laser-Assisted Bioprinting, Microfluidic And Acoustic, Magnetic Levitation, Hybrid Or 4D
3) By Materials: Natural Biomaterials, Synthetic Biomaterials, Decellularized Extracellular Matrices, Hydrogels, Composite Materials, Other Materials
4) By Application: Tissue Engineering, Cosmetic Surgery, Drug Testing And Development, Food Testing
5) By End-User: Pharmaceutical Companies, Biotechnology Firms, Academic Research Institutions, Contract Research Organizations, Hospitals And Clinics
Subsegments:
1) By Skin: Wound Healing Applications, Cosmetic Testing Models, Skin Graft Replacements
2) By Cartilage: Joint Repair Models, Nasal Reconstruction, Ear Reconstruction
3) By Liver: Toxicity Testing Models, Disease Modeling, Transplant Research
4) By Bone: Orthopedic Implants, Cranial Repair Models, Bone Graft Substitutes
5) By Heart: Cardiac Patch Development, Heart Valve Models, Myocardial Regeneration
6) By Other Tissue Types: Kidney Models, Lung Tissue Constructs, Pancreatic Tissue Models
What New Market Trends Are Emerging in the 3D Bioprinted Human Tissue Market?
Major companies operating in the 3D bioprinted human tissue market are focusing on developing innovative approaches, such as patient-derived sample optimization, to create highly accurate and personalized tissue models that improve drug testing, disease research, and regenerative medicine outcomes. Patient-derived sample optimization is the enhanced ability to efficiently use limited patient cells to create multiple high-quality, biologically relevant 3D tissue models for more accurate and personalized research outcomes. For instance, in January 2025, Inventia Life Science Pty Ltd., an Australia-based biotechnology company, launched the RASTRUM solution as part of its Inventia Life Science suite, specifically designed to enhance the rapid, precise, and reproducible creation of complex 3D human tissue models that closely mimic real human tissues for use in drug discovery, disease modeling, and regenerative medicine. It uses advanced drop-on-demand bioprinting technology to automate and scale the production of 3D cell cultures in standard lab plate formats, significantly reducing manual effort and variability. This allows researchers to conduct high-throughput, consistent experiments with biologically relevant tissue models, helping to accelerate discoveries and improve the predictability of preclinical research outcomes.
Who Are the Major Companies Operating in the 3D Bioprinted Human Tissue Market?
Major companies operating in the 3D bioprinted human tissue market are 3D Systems Corporation, Inventia Life Science PTY LTD., Aspect Biosystems Ltd., Cellink Global AB, Prellis Biologics Inc., Cyfuse Biomedical K.K., Poietis SAS, Fluidform LLC, Tissuelabs, Brinter Oy, EpiBone Inc., Carcinotech Ltd., VoxCell BioInnovation Inc., Organovo Holdings Inc., Biolife 4D, Vivax-bio, CollPlant Biotechnologies Ltd., Xolo, Copner Biotech, and TissueTinker.
Get the detailed 3d bioprinted human tissue market report today
https://www.thebusinessresearchcompany.com/report/3d-bioprinted-human-tissue-global-market-report
Which Region Holds the Largest Share of the 3D Bioprinted Human Tissue Market?
North America was the largest region in the 3D bioprinted human tissue market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3d bioprinted human tissue market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment